L5 Capital Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-12 06:06 am Purchase |
2024-12-10 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 268,758 10.700% |
5,167 (+1.96%) |
Filing |
| 2024-12-10 06:06 am Purchase |
2024-12-06 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 263,591 10.500% |
7,667 (+3.00%) |
Filing |
| 2024-12-05 07:45 am Purchase |
2024-12-03 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 255,925 10.000% |
75,729 (+42.03%) |
Filing |
| 2024-05-24 08:58 am Purchase |
2024-05-14 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 180,196 14.700% |
78,196 (+76.66%) |
Filing |
| 2021-09-07 4:05 pm Unchanged |
2021-09-01 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 102,000 10.000% |
0 (Unchanged) |
Filing |
| 2021-08-04 09:43 am Purchase |
2021-08-03 | 13G | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 102,000 10.000% |
53,667 (+111.03%) |
Filing |
| 2021-06-28 4:15 pm Purchase |
2021-06-21 | 13G | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 48,333 5.010% |
48,333 (New Position) |
Filing |